VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

Clinical trial NCT06320951 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06320951
Sponsor: University of Alabama at Birmingham
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cardiovascular Diseases Insulin Sensitivity/Resistance Metabolic Disease Metabolism Energy Expenditure Obesity

Start date: 2026-12-01
Primary completion: 2028-04-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.